Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 64
- +2 vs. Q2 2021
- Portfolio value
- $147.0M
- −$20.2M (−12.1%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 796,106 | $47.1M | 32.1% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,252,388 | $13.1M | 8.9% | +19,531+0.9% | Added | History |
| BDSXBiodesix Inc | COM | 1,104,953 | $9.08M | 6.2% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 59,684 | $8.42M | 5.7% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 80,200 | $7.69M | 5.2% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 314,143 | $4.38M | 3.0% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 12,600 | $3.57M | 2.4% | +500+4.1% | Added | History |
| ALBOAlbireo Pharma, Inc. | COM | 113,000 | $3.53M | 2.4% | +2,000+1.8% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 18,000 | $3.32M | 2.3% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 199,400 | $3.31M | 2.3% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 40,247 | $2.87M | 2.0% | +10,000+33.1% | Added | History |
| MASIMasimo Corp | COM | 8,000 | $2.17M | 1.5% | 00.0% | Unchanged | History |
| XLRNAcceleron Pharma Inc | COM | 10,672 | $1.84M | 1.3% | −8,000−42.8% | Reduced | History |
| CLRContinental Resources, Inc | COM | 38,600 | $1.78M | 1.2% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 180,000 | $1.64M | 1.1% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 84,000 | $1.60M | 1.1% | +10,000+13.5% | Added | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.54M | 1.0% | 00.0% | Unchanged | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 300,000 | $1.53M | 1.0% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 246,000 | $1.43M | 1.0% | +16,000+7.0% | Added | History |
| BHVNBiohaven Ltd. | COM | 10,000 | $1.39M | 0.9% | 00.0% | Unchanged | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 80,000 | $1.37M | 0.9% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.35M | 0.9% | 00.0% | Unchanged | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 22,000 | $1.31M | 0.9% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 72,000 | $1.29M | 0.9% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $1.23M | 0.8% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 34,200 | $1.12M | 0.8% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 190,000 | $1.08M | 0.7% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 45,114 | $1.02M | 0.7% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $984.0K | 0.7% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $894.0K | 0.6% | +15,000+150.0% | Added | History |
| PGNYProgyny, Inc. | COM | 15,000 | $840.0K | 0.6% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM | 876,899 | $811.0K | 0.6% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $810.0K | 0.6% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $698.0K | 0.5% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $673.0K | 0.5% | +28,000+280.0% | Added | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $633.0K | 0.4% | 00.0% | Unchanged | History |
| NARIInari Medical, Inc. | Stock | 7,000 | $568.0K | 0.4% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $537.0K | 0.4% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 8,000 | $533.0K | 0.4% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 54,392 | $531.0K | 0.4% | −6,223−10.3% | Reduced | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 8,000 | $531.0K | 0.4% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 40,000 | $503.0K | 0.3% | +40,000 | New | History |
| TGTXTG Therapeutics, Inc. | COM | 15,000 | $499.0K | 0.3% | 00.0% | Unchanged | History |
| ChemoCentryx, Inc.16383L106 | COM | 25,000 | $428.0K | 0.3% | −5,000−16.7% | Reduced | – |
| BIORBiora Therapeutics, Inc. | COM | 270,000 | $410.0K | 0.3% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 12,300 | $402.0K | 0.3% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 12,000 | $396.0K | 0.3% | +4,000+50.0% | Added | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $382.0K | 0.3% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $363.0K | 0.2% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 50,000 | $348.0K | 0.2% | +20,000+66.7% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $342.0K | 0.2% | +10,000+50.0% | Added | History |
| AWHLAspira Women's Health Inc. | COM | 103,104 | $335.0K | 0.2% | 00.0% | Unchanged | History |
| AKBAAkebia Therapeutics, Inc. | COM | 100,000 | $288.0K | 0.2% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $287.0K | 0.2% | 00.0% | Unchanged | History |
| LSFLaird Superfood, Inc. | COM STK | 14,000 | $267.0K | 0.2% | 00.0% | Unchanged | History |
| AVEOAveo Pharmaceuticals, Inc. | COM NEW | 40,000 | $247.0K | 0.2% | +40,000 | New | History |
| ISEEIVERIC bio, Inc. | COM | 15,000 | $244.0K | 0.2% | +15,000 | New | History |
| IRTCiRhythm Holdings, Inc. | COM | 4,000 | $234.0K | 0.2% | +4,000 | New | History |
| SIENProject Sage Oldco, Inc. | COM | 40,000 | $229.0K | 0.2% | 00.0% | Unchanged | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 9,000 | $215.0K | 0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 70,000 | $181.0K | 0.1% | 00.0% | Unchanged | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,785 | $113.0K | 0.1% | +18,785 | New | History |
| TXMDTherapeuticsMD, Inc. | COM | 100,000 | $74.0K | 0.1% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $65.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2021 (3)
Positions held at the end of Q2 2021 that are gone from this filing.